Detalhe da pesquisa
1.
The Pancreatic Cancer Early Detection (PRECEDE) Study is a Global Effort to Drive Early Detection: Baseline Imaging Findings in High-Risk Individuals.
J Natl Compr Canc Netw
; 22(3): 158-166, 2024 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38626807
2.
Standardization of MRI Screening and Reporting in Individuals With Elevated Risk of Pancreatic Ductal Adenocarcinoma: Consensus Statement of the PRECEDE Consortium.
AJR Am J Roentgenol
; 219(6): 903-914, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35856454
3.
Cancer surveillance awareness and practice among families at increased risk for pancreatic adenocarcinoma.
Cancer
; 127(13): 2271-2278, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33721345
4.
Comparing models of delivery for cancer genetics services among patients receiving primary care who meet criteria for genetic evaluation in two healthcare systems: BRIDGE randomized controlled trial.
BMC Health Serv Res
; 21(1): 542, 2021 Jun 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34078380
5.
Secondary findings from clinical genomic sequencing: prevalence, patient perspectives, family history assessment, and health-care costs from a multisite study.
Genet Med
; 21(5): 1100-1110, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30287922
6.
Correction: Secondary findings from clinical genomic sequencing: prevalence, patient perspectives, family history assessment, and health-care costs from a multisite study.
Genet Med
; 21(5): 1261-1262, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30670880
7.
Physician Experiences and Understanding of Genomic Sequencing in Oncology.
J Genet Couns
; 27(1): 187-196, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28840409
8.
Recommendations for a More Organized and Effective Approach to the Early Detection of Pancreatic Cancer From the PRECEDE (Pancreatic Cancer Early Detection) Consortium.
Gastroenterology
; 161(6): 1751-1757, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34454916
9.
Traditional roles in a non-traditional setting: genetic counseling in precision oncology.
J Genet Couns
; 23(4): 655-60, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24578120
10.
Impact of comprehensive family history and genetic analysis in the multidisciplinary pancreatic tumor clinic setting.
Cancer Med
; 12(3): 2345-2355, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35906821
11.
Racial, Ethnic, and Sex-based Disparities among High-risk Individuals Undergoing Pancreatic Cancer Surveillance.
Cancer Prev Res (Phila)
; 16(6): 343-352, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37259800
12.
Incorporating genetic counseling into clinical care for children and adolescents with cancer.
Future Oncol
; 12(7): 883-6, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26888175
13.
Impact of changing guidelines on genetic testing and surveillance recommendations in a contemporary cohort of breast cancer survivors with family history of pancreatic cancer.
Sci Rep
; 11(1): 12491, 2021 06 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34127761
14.
An oncocytic adrenal tumour in a patient with Birt-Hogg-Dubé syndrome.
Clin Endocrinol (Oxf)
; 80(6): 925-7, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23848572
15.
Outcomes of genetic evaluation for hereditary cancer syndromes in unaffected individuals.
Fam Cancer
; 14(1): 167-74, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25245322
16.
The clinical phenotype of SDHC-associated hereditary paraganglioma syndrome (PGL3).
J Clin Endocrinol Metab
; 99(8): E1482-6, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24758179
17.
Screening for germline mismatch repair mutations following diagnosis of sebaceous neoplasm.
JAMA Dermatol
; 150(12): 1315-21, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25006859
18.
Prevalence of germline TP53 mutations in a prospective series of unselected patients with adrenocortical carcinoma.
J Clin Endocrinol Metab
; 98(1): E119-25, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23175693
19.
Adrenocortical carcinoma is a lynch syndrome-associated cancer.
J Clin Oncol
; 31(24): 3012-8, 2013 Aug 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-23752102
20.
Disclosing individual CDKN2A research results to melanoma survivors: interest, impact, and demands on researchers.
Cancer Epidemiol Biomarkers Prev
; 20(3): 522-9, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21307304